β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties.
Fidyt K, Fiedorowicz A, Strządała L, Szumny A. · 2016
Read β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties. by Fidyt K, Fiedorowicz A, Strządała L, Szumny A. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5083753.txt.
Description
Klaudyna Fidyt, Anna Fiedorowicz, Leon Strządała, and Antoni Szumny review two plant compounds in Cancer Medicine in 2016. Beta-caryophyllene and its oxide are scent chemicals in many plants. Both slow numerous cancer cells in the lab, and both can raise the amount of standard chemotherapy drugs that gets inside cells. Yet their action inside living animals is barely tested.
The two compounds part ways at one key point. The parent compound switches on the CB2 cannabinoid receptor, the one outside the brain, which may explain pain relief without a high. The oxide does not bind those receptors and instead perturbs cancer pathways such as MAPK and PI3K/AKT/mTOR, cutting pro-growth proteins and raising cell-death ones. Together, the pair offers a rare double action: against tumors and against cancer pain. The authors propose testing mixtures of the two alongside standard drugs in animals.
Catalog record
| CREATOR | Fidyt K, Fiedorowicz A, Strządała L, Szumny A. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |